[Therapy of outbreaks of Duhring-Brocq disease: the combination of hexacycline or rovamycin or aureomycin (vitamin B complex) with nivaquine, Fowler's solution and vitamin B 12].
D000900:Anti-Bacterial Agents / Q000628:therapy*; D001151:Arsenic / Q000628:therapy*; D018053:Arsenites; D002738:Chloroquine / Q000628:therapy*; D002751:Chlortetracycline; D045728:Corrinoids; D003874:Dermatitis Herpetiformis / Q000628:therapy*; D004196:Disease Outbreaks; D005492:Folic Acid; D006801:Humans; D017680:Potassium Compounds; D015572:Spiramycin; D014805:Vitamin B 12 / Q000628:therapy*; D014803:Vitamin B Complex
D000900:Anti-Bacterial Agents; D018053:Arsenites; D045728:Corrinoids; D017680:Potassium Compounds; D014803:Vitamin B Complex; C009003:potassium arsenite solution; D015572:Spiramycin; D002738:Chloroquine; D005492:Folic Acid; D001151:Arsenic; D014805:Vitamin B 12; D002751:Chlortetracycline
ANTIBIOTICS/therapy; ARSENIC/therapy; CHLOROQUINE/therapy; DERMATITIS HERPETIFORMIS/therapy; VITAMIN B 12/therapy